Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioNTech SE - American Depositary Shares (NQ: BNTX )

115.78 +3.34 (+2.98%)
Streaming Delayed Price Updated: 10:12 AM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 129,614
Open 114.31
Bid (Size) 115.60 (1)
Ask (Size) 115.96 (1)
Prev. Close 112.43
Today's Range 113.66 - 116.73
52wk Range 76.53 - 131.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025. 
Via Investor's Business Daily
BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
From BioNTech SE
Via GlobeNewswire

Performance

YTD
+0.41%
+0.41%
1 Month
+1.36%
+1.36%
3 Month
-1.49%
-1.49%
6 Month
+33.35%
+33.35%
1 Year
+16.27%
+16.27%

More News

Read More
Why BioNTech (BNTX) Shares Are Volatile Today
Via Benzinga
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Via Benzinga
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
Via Investor's Business Daily
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Critical Insights From BioNTech Analyst Ratings: What You Need To Know
Via Benzinga
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Via Benzinga
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike
Via Investor's Business Daily
Exposures COVID-19
5 Predictions for the Stock Market in 2025 -- and Which Stocks Will Soar the Most If They're Right
Via The Motley Fool
Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy
Via Investor's Business Daily
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool
The Analyst Landscape: 17 Takes On BioNTech
Via Benzinga
What Analysts Are Saying About BioNTech Stock
Via Benzinga
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
2 No-Brainer Stocks to Buy Before the End of 2024
Via The Motley Fool
Why Is BioNTech Stock Trading Higher On Friday?
Via Benzinga
5 Top Stocks to Buy in December
Via The Motley Fool
This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
Via Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Via Benzinga
Exposures Product Safety
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Via Investor's Business Daily
Topics Government
Exposures Political
BioNTech Stock Got A IBD RS Rating Lift
Via Investor's Business Daily
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
Via Benzinga
BioNTech to Acquire Biotheus to Boost Oncology Strategy
From BioNTech SE
Via GlobeNewswire
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.